Pulmonary sarcoidosis with a cavitary lesion in the lung caused by a TNF‐α inhibitor: A case report

Pulmonary sarcoidosis with a cavitary lesion in the lung caused by a TNF‐α inhibitor: A case report

Abstract A 28‐year‐old man with ankylosing spondylitis (AS) who was treated with a tumour necrosis factor‐alpha (TNF‐α) inhibitor, adalimumab, presented with newly detected multiple bilateral pulmonary nodules on chest computed tomography (CT). We suspected bacterial infection, including those cause...

Full description

Bibliographic Details
Main Authors: Eriko Hamada, Yoshifumi Yamamoto, Yosuke Okuda, Kazuhiro Sakaguchi, Kentaro Suzuki, Yoshiro Kai, Maiko Takeda, Shigeto Hontsu, Motoo Yamauchi, Masanori Yoshikawa, Noriyoshi Sawabata, Chiho Ohbayashi, Shigeo Muro
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Respirology Case Reports
Subjects:
adalimumab
ankylosing spondylitis
interleukin‐17
sarcoidosis
tumour necrosis factor‐alpha
Online Access:https://doi.org/10.1002/rcr2.1065

Internet

https://doi.org/10.1002/rcr2.1065

Similar Items